Palliative Care in Maternity and Neonatology (VESPAN)

May 19, 2026 updated by: University Hospital, Lille

How Parents (and Their Child if They Continue Their Life) Fare After a Decision of Palliative Care Has Been Taken in the Neonatal Period

Palliative care is now an accepted principle in most maternity and neonatology wards, however not much is known about its psychological and social consequences on families. Some children continue their life after a palliative care decision has been taken. In France, quality of life and the neuro-developmental evolution of newborns who continue their life after a palliative care decision has been taken, have never been studied.

Study Overview

Study Type

Observational

Enrollment (Actual)

1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Arras, France
        • CH Arras
      • Lens, France
        • CH LENS
      • Lille, France, 59037
        • Hop Jeanne de Flandre Chu Lille
      • Valenciennes, France
        • Ch Valenciennes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

children and parents followed in pediatric unit whom a decision of palliative care has been made in the neonatal period

Description

Inclusion Criteria:

  • Father and/or Mother of a child, who is alive or not, for whom a decision of palliative care has been made in the neonatal period
  • Under the care of one of the Level 3 Maternity Centers in the North and Pas-de-Calais departments (Arras, Lens, Lille, Valenciennes) since 2018
  • Written consent of the two legal guardians of the child allowing the collection of data concerning the child
  • Written consent of the parent(s) participating to this study by completing the parental questionnaires

Exclusion Criteria:

  • Medico-legal complaint underway
  • Parents who do not understand French
  • Parents or children who are under legal protection (guardianship, curatorship)
  • Parents or children who are not Social Security beneficiaries

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Parents only
Exploring the psychological and social impact on parents of a palliative care decision concerning their child in the neonatal period
Assessing the neuro-developmental evolution of children and understanding the determinants of the psychological and social impact of palliative care decisions on parents
Scales : Hospital Anxiety and Depression, Intolerance to Uncertainty, and Brief COPE.
Children and Parents
Assessing the neuro-developmental evolution of children and understanding the determinants of the psychological and social impact of palliative care decisions on parents

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Semi Structured interview
Time Frame: 24 months after palliative care decision
Parents : Exploring the psychological and social impact of the palliative care decision 2 hours semi structured interviews will be done to describe the psychological and social impact a decision of palliative care concerning their newborn infant has on parents.
24 months after palliative care decision

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Ages and Stages Questionnaire (ASQ) - Clinical Examination of Child
Time Frame: 24 months after palliative care decision
Child : Neuro-Developmental Assessment
24 months after palliative care decision
Semi Structured Interview
Time Frame: 24 months after palliative care decision
Parents : Determinants of the psychological and social impact of the palliative care decision
24 months after palliative care decision
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 24 months after palliative care decision
Parents :Psychometric Measure of Anxiety and Depression The scale allows to detect anxiety and depression using 14 items rated from 0-3.
24 months after palliative care decision
Intolerance to Uncertainty Scale (EEI)
Time Frame: 24 months after palliative care decision
Parents : Psychometric Measure of Intolerance to Uncertainty This questionnaire contains 27 items measuring emotions, cognitions and behaviours in ambiguous situations, the consequences of being uncertain and attempts to control the future.Items are rated on a Likert scale from 1 ("Not at all matching") to 5 ("Very matching"). The total share is obtained by adding the items.
24 months after palliative care decision
Brief COPE
Time Frame: 24 months after palliative care decision
Parents : Psychometric Measure of Coping Strategies The Brief-COPE is a 28 item self-report questionnaire withs scoring and interpretation: Positive reframing / Planning/ Humor / Religion/Self-blame
24 months after palliative care decision

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Laurent Storme, MD,PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 12, 2020

Primary Completion (Actual)

August 31, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

October 14, 2020

First Submitted That Met QC Criteria

November 5, 2020

First Posted (Actual)

November 6, 2020

Study Record Updates

Last Update Posted (Actual)

May 22, 2026

Last Update Submitted That Met QC Criteria

May 19, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Neonatal Critical Care

Clinical Trials on Semi-structured interviews

Subscribe